Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof

摘要

The present disclosure relates to pharmaceutical formulations including abiraterone and a cyclic oligomer, as well as tablets including such pharmaceutical formulations, methods of forming such pharmaceutical formulations, and methods of administering such pharmaceutical formulations or tablets.